{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System Aztreonam (0.5-64 \u00b5g/mL)",
        "BD Phoenix\u2122 Automated Microbiology System Aztreonam (0.5-64 \u00b5g/mL) - Gram-Negative ID/AST or AST only"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K063824",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322",
        "K033558"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "February 14, 2007",
    "Summary Letter Received Date": "December 26, 2006",
    "Submission Date": "December 22, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Aztreonam"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution",
        "Automated detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Reagent",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System with aztreonam (0.5-64 \u00b5g/mL) antimicrobial susceptibility testing for Gram-negative bacteria",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of most Gram-negative aerobic and facultative anaerobic bacteria isolates and most Gram-positive isolates from pure culture, using aztreonam (0.5-64 \u00b5g/mL) in Gram-negative ID/AST or AST only Phoenix panels",
    "fda_folder": "Microbiology"
}